Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01332825 · ClinicalTrials.gov registry record · NA
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
A NA study of Olfactory Disorder, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT01332825: Completed NA study of Olfactory Disorder, sponsored by University of Washington.
NCT01332825 is a NA study of Olfactory Disorder that has completed, run by University of Washington. The registered enrollment target is 41 participants, below the 96-participant average among 3 other Olfactory Disorder trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01332825, a NA study of Olfactory Disorder, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP levels and if nasal irrigation is capable of harvesting olfactory cilia. The investigators hypothesize that nasal saline will have no effect on olfaction and will be inadequate to harvest olfactory cilia.
Primary Outcome
validated, scratch and sniff smell identification test
Conditions Studied
Interventions
- OTHER saline nasal irrigation
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01332825 record still lists
NCT01332825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 96-participant average among 3 other Olfactory Disorder trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Olfactory Disorder appearing as the primary indexed condition, and to 1 intervention - of which saline nasal irrigation is the first listed.
NCT01332825 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01332825 about?
NCT01332825 is a clinical study titled "cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose". The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP level...
What is the current status of trial NCT01332825?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2011-03. Estimated completion is 2012-12.
What conditions does trial NCT01332825 study?
This clinical trial studies the following conditions: Olfactory Disorder.
What interventions are being tested in trial NCT01332825?
The interventions under investigation include: saline nasal irrigation (OTHER).
Who is sponsoring clinical trial NCT01332825?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01332825 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Olfactory Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia